TY  - JOUR

T1  - The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

JO  - Health Technol Assess

PY  - 2012/04/01

AU  - Bond M

AU  - Rogers G

AU  - Peters J

AU  - Anderson R

AU  - Hoyle M

AU  - Miners A

AU  - Moxham T

AU  - Davis S

AU  - Thokala P

AU  - Wailoo A

AU  - Jeffreys M et al

ED  - 

DO  - DOI: 10.3310/hta16210

VL  - 16

IS  - 21

SP  - 1

EP  - 470

Y2  - 2024/12/22

ER  -